MMP9 and hepatocellular carcinoma: Our research proves that RIPK4 can inhibit the phosphorylation of STAT3 in HCC cells, resulting in the downregulation of target gene matrix metalloproteinases (MMP-2 and MMP-9), thereby inhibiting the invasion and metastasis of HCC.